Position history for DnB Asset Management AS's holdings in ACADIA PHARMACEUTICALS INC
DnB Asset Management AS holds 18,523 shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $412,322 as of 2026-Q1. The position was increased (+26.0% shares). ACAD represents 0.0% of DnB Asset Management AS's portfolio.
Current Value
$412,322
Current Shares
18,523
Total Value Change
+$247,791
Total Shares Change
+8,398
Other major holders of ACAD: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 18,523 |
+26.0% |
| $412,322 |
| 0.0% |
| $22.50 |
29 |
| 2025-Q4 | Increased | 14,702 | +11.6% | $392,690 | 0.0% | $26.70 | 27 |
| 2025-Q3 | Increased | 13,177 | +20.7% | $281,197 | 0.0% | $21.32 | 28 |
| 2025-Q2 | Decreased | 10,919 | -30.1% | $235,523 | 0.0% | $22.12 | 0 |
| 2025-Q1 | Increased | 15,611 | +9.9% | $259,299 | 0.0% | $17.07 | 26 |
| 2024-Q4 | Increased | 14,202 | +38.7% | $260,607 | 0.0% | $16.69 | 31 |
| 2024-Q3 | Increased | 10,238 | +1.1% | $157,460 | 0.0% | $15.69 | 23 |
| 2024-Q2 | New | 10,125 | - | $164,531 | 0.0% | $16.25 | 31 |